SNSE - Panacea Pharmaceuticals, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Regeneron, Sensei in clinical supply agreement for tumor studies
• Sensei to shut Boston research site, cut workforce by ~40%
• Sensei Biotherapeutics GAAP EPS of -$0.44 misses by $0.09
• Sensei Biotherapeutics GAAP EPS of -$0.34 beats by $0.06
• Sensei Biotherapeutics GAAP EPS of -$0.40 misses by $0.05
• Sensei Biotherapeutics GAAP EPS of -$1.33 misses by $0.01
• Sensei Biotherapeutics names Erin Colgan as CFO
• Sensei Biotherapeutics gains 7% on being added to Nasdaq Biotechnology index
• Sensei Biotherapeutics adds Kristian Humer to its board of directors
• Cerevel Therapeutics, Avinger leads healthcare gainers; DiaMedica Therapeutics, MediWound among major losers
• Sensei downgraded, PT cut on program discontinuation, Gilead's Yescarta data, and more in analyst action
• Sensei Biotherapeutics reprioritizes pipeline programs, provides cash runway update
• ASCO 2021: What to look forward to at critical pharma industry conference
• Sensei Biotherapeutics shares rise on early-stage SNS-301 cancer data
• Sensei Biotherapeutics EPS misses by $0.09
• Sensei Biotherapeutics EPS of -$12.53
• Sensei shares surge 6% premarket as Citi initiates buy rating